Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.900
-0.060 (-2.03%)
At close: May 30, 2025, 4:00 PM
3.040
+0.140 (4.83%)
After-hours: May 30, 2025, 4:02 PM EDT
Kalaris Therapeutics Employees
Kalaris Therapeutics had 14 employees as of December 31, 2024.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$5,425,429
Market Cap
54.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
KLRS News
- 8 days ago - Kalaris to Participate at Stifel Ophthalmology Forum - GlobeNewsWire
- 17 days ago - Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - GlobeNewsWire
- 2 months ago - Kalaris Announces Closing of Merger with AlloVir - GlobeNewsWire